Search Ontology:
ChEBI

brivanib alaninate

Term ID
CHEBI:167656
Synonyms
  • (1R,2S)-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
  • (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-yl (2S)-2-aminopropanoate
  • (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-yl L-alaninate
  • alaninate de brivanib
  • alaninati brivanibum
  • alaninato de brivanib
  • BMS 582664
  • BMS-582664
  • BMS582664
  • brivanib alaninate
Definition
A carboxylic ester resulting from the formal condensation of the carboxy group of L-alanine with the hydroxy group of brivanib. It is a prodrug of brivanib (BMS-540215), a potent oral dual inhibitor of VEGFR-2 and FGFR-1 (IC50 of 25 nM and 148 nM, respectively) and was in development for the treatment of hepatocellular and colon carcinomas.
References
  • cas:649735-63-7
  • chemspider:9330033
  • drugbank:DB11865
  • kegg.drug:D08878
  • pubmed:16570908
  • pubmed:17638901
  • pubmed:18288793
  • pubmed:18815076
  • pubmed:18829493
  • pubmed:19396600
  • pubmed:20024612
  • pubmed:20303261
  • pubmed:21115896
  • pubmed:21289073
  • pubmed:21391890
  • pubmed:21629245
  • pubmed:21659627
  • pubmed:22189636
  • pubmed:22983304
  • pubmed:23030483
  • pubmed:23690424
  • pubmed:24325631
  • pubmed:24780101
  • pubmed:25470221
  • pubmed:25724158
  • pubmed:26852852
  • pubmed:27771049
  • pubmed:30855507
  • wikipedia.en:Brivanib_alaninate
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from brivanib alaninate
Phenotype where environments contain brivanib alaninate
Phenotype modified by environments containing brivanib alaninate
Phenotype affecting brivanib alaninate
Human Disease Model